Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 519

1.

Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.

Swarts DR, Ramaekers FC, Speel EJ.

Biochim Biophys Acta. 2012 Dec;1826(2):255-71. doi: 10.1016/j.bbcan.2012.05.001. Epub 2012 May 10. Review.

PMID:
22579738
2.

Malignancy-associated X chromosome allelic losses in foregut endocrine neoplasms: further evidence from lung tumors.

D'Adda T, Bottarelli L, Azzoni C, Pizzi S, Bongiovanni M, Papotti M, Pelosi G, Maisonneuve P, Antonetti T, Rindi G, Bordi C.

Mod Pathol. 2005 Jun;18(6):795-805.

3.

Genetic changes in the spectrum of neuroendocrine lung tumors.

Onuki N, Wistuba II, Travis WD, Virmani AK, Yashima K, Brambilla E, Hasleton P, Gazdar AF.

Cancer. 1999 Feb 1;85(3):600-7.

PMID:
10091733
4.

Differential retinoblastoma and p16(INK4A) protein expression in neuroendocrine tumors of the lung.

Dosaka-Akita H, Cagle PT, Hiroumi H, Fujita M, Yamashita M, Sharma A, Kawakami Y, Benedict WF.

Cancer. 2000 Feb 1;88(3):550-6.

PMID:
10649246
5.

Unbalanced chromosomal aberrations in neuroendocrine lung tumors as detected by comparative genomic hybridization.

Ullmann R, Schwendel A, Klemen H, Wolf G, Petersen I, Popper HH.

Hum Pathol. 1998 Oct;29(10):1145-9.

PMID:
9781656
6.

Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.

Przygodzki RM, Finkelstein SD, Langer JC, Swalsky PA, Fishback N, Bakker A, Guinee DG, Koss M, Travis WD.

Am J Pathol. 1996 May;148(5):1531-41.

7.

Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids.

Sturm N, Rossi G, Lantuejoul S, Papotti M, Frachon S, Claraz C, Brichon PY, Brambilla C, Brambilla E.

Hum Pathol. 2002 Feb;33(2):175-82.

PMID:
11957142
8.

Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors.

Brambilla E, Negoescu A, Gazzeri S, Lantuejoul S, Moro D, Brambilla C, Coll JL.

Am J Pathol. 1996 Dec;149(6):1941-52.

9.

The position of pulmonary carcinoids within the spectrum of neuroendocrine tumors of the lung and other tissues.

Ullmann R, Petzmann S, Klemen H, Fraire AE, Hasleton P, Popper HH.

Genes Chromosomes Cancer. 2002 May;34(1):78-85.

PMID:
11921285
10.

Divergent cyclin B1 expression and Rb/p16/cyclin D1 pathway aberrations among pulmonary neuroendocrine tumors.

Igarashi T, Jiang SX, Kameya T, Asamura H, Sato Y, Nagai K, Okayasu I.

Mod Pathol. 2004 Oct;17(10):1259-67.

11.

Mechanism of retinoblastoma gene inactivation in the spectrum of neuroendocrine lung tumors.

Gouyer V, Gazzéri S, Bolon I, Drevet C, Brambilla C, Brambilla E.

Am J Respir Cell Mol Biol. 1998 Feb;18(2):188-96.

PMID:
9476905
12.

MEN1 gene mutation analysis of high-grade neuroendocrine lung carcinoma.

Debelenko LV, Swalwell JI, Kelley MJ, Brambilla E, Manickam P, Baibakov G, Agarwal SK, Spiegel AM, Marx SJ, Chandrasekharappa SC, Collins FS, Travis WD, Emmert-Buck MR.

Genes Chromosomes Cancer. 2000 May;28(1):58-65.

PMID:
10738303
13.

Molecular alterations to human chromosome 3p loci in neuroendocrine lung tumors.

Kovatich A, Friedland DM, Druck T, Hadaczek P, Huebner K, Comis RL, Hauck W, McCue PA.

Cancer. 1998 Sep 15;83(6):1109-17.

PMID:
9740075
14.

Advances in neuroendocrine lung tumors.

Travis WD.

Ann Oncol. 2010 Oct;21 Suppl 7:vii65-71. doi: 10.1093/annonc/mdq380. Review.

15.

Independent value of fascin immunoreactivity for predicting lymph node metastases in typical and atypical pulmonary carcinoids.

Pelosi G, Pasini F, Fraggetta F, Pastorino U, Iannucci A, Maisonneuve P, Arrigoni G, De Manzoni G, Bresaola E, Viale G.

Lung Cancer. 2003 Nov;42(2):203-13.

PMID:
14568688
16.

Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.

Pelosi G, Scarpa A, Puppa G, Veronesi G, Spaggiari L, Pasini F, Maisonneuve P, Iannucci A, Arrigoni G, Viale G.

Cancer. 2005 Mar 15;103(6):1154-64.

17.

Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization.

Walch AK, Zitzelsberger HF, Aubele MM, Mattis AE, Bauchinger M, Candidus S, Präuer HW, Werner M, Höfler H.

Am J Pathol. 1998 Oct;153(4):1089-98. Review.

18.

The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung.

Beasley MB, Lantuejoul S, Abbondanzo S, Chu WS, Hasleton PS, Travis WD, Brambilla E.

Hum Pathol. 2003 Feb;34(2):136-42.

PMID:
12612881
19.

[Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].

Langfort R, Rudziński P, Burakowska B.

Pneumonol Alergol Pol. 2010;78(1):33-46. Review. Polish.

20.

TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location.

Du EZ, Goldstraw P, Zacharias J, Tiffet O, Craig PJ, Nicholson AG, Weidner N, Yi ES.

Hum Pathol. 2004 Jul;35(7):825-31.

PMID:
15257545
Items per page

Supplemental Content

Write to the Help Desk